Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
Cells|March 13, 2024
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular DiseaseHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.Journal of Clinical Medicine Research|April 18, 2015
Effects of 6-month sitagliptin treatment on metabolic parameters in diabetic patients taking oral glucocorticoids: a retrospective cohort studyHisayuki Katsuyama, Akahito Sako, Hiroki Adachi, et al.Journal of Clinical Medicine|August 29, 2024
Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese PatientsHisayuki Katsuyama, Seiichi Horinaka, Mariko Hakoshima, et al.International Journal of Molecular Sciences|October 28, 2023
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and TreatmentsHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.Journal of Clinical Medicine Research|February 9, 2023
Clinical, Hematological, Biochemical and Radiological Characteristics for Patients With Splenic Infarction: Case Series With Literature ReviewMariko Hakoshima, Kazuya Kitakaze, Hiroki Adachi, et al.Biomolecules|August 29, 2024
The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular DiseaseHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.World Journal of Diabetes|February 17, 2015
Causative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetesHidekatsu Yanai, Hiroki Adachi, Hisayuki Katsuyama, et al.Clinical and Experimental Nephrology|January 5, 2021
Role and expression of non-classical human leukocyte antigen-G in renal transplanted allograftsSho Kumano, Yuki Okushi, Keiji Fujimoto, et al.Diabetes Research and Clinical Practice|June 22, 2024
Real-world effectiveness of imeglimin in patients with type 2 diabetes: A retrospective longitudinal study in JapanHisayuki Katsuyama, Mariko Hakoshima, Takahiro Heshiki, et al.Modern Rheumatology|June 2, 2022
Use of biologics for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: Information from a Japanese hospital claims databaseYusuke Narita, Takashi Funatogawa, Kazuma Mii, et al.Pageof 8